Articles

TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells

Department of Medical Oncology, Inselspital, Bern University Hospital;Division of Experimental Pathology, Institute of Pathology, University of Bern;Department for BioMedical Research (DBMR), University of Bern
Interfaculty Bioinformatics Unit, Department for BioMedical Research, and Swiss Institute of Bioinformatics, University of Bern
Department of Medical Oncology, Inselspital, Bern University Hospital;Division of Experimental Pathology, Institute of Pathology, University of Bern;Department for BioMedical Research (DBMR), University of Bern
Institute of Pathology and Medical Genetics, University of Basel
Institute of Pathology and Medical Genetics, University of Basel
Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel
Interfaculty Bioinformatics Unit, Department for BioMedical Research, and Swiss Institute of Bioinformatics, University of Bern
Institute of Pathology and Medical Genetics, University of Basel
Department of Medical Oncology, Inselspital, Bern University Hospital;Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Switzerland
Department of Medical Oncology, Inselspital, Bern University Hospital;Department for BioMedical Research (DBMR), University of Bern
Vol. 104 No. 4 (2019): April, 2019 https://doi.org/10.3324/haematol.2018.201590